Journal menu

Journal of Cancer Chemotherapy

+44 7723 860457
Awards Nomination 15+ Million Readerbase Google Scholar citation report

Indexed In

Open J Gate Genamics JournalSeek RefSeek Hamdard University EBSCO A-Z OCLC- WorldCat Publons Geneva Foundation for Medical Education and Research Euro Pub Google Scholar

Journal Highlights

Global Chemo Access
Biomarkers in Action
Pediatric Chemo Advances
Chemoimmunotherapy Synergy
Nano-Chemo Innovations
Personalized Cancer Dosing
Next-Gen Chemotherapeutics
Overcoming Drug Resistance

Useful Links

  • Editor-in-Chief
  • Editorial Board
  • Instructions for Authors
  • Publication ethics & malpractice statement
  • Submit Manuscript
  • Aims and Scope
  • Articles in process
  • Archive
  • Contact

    • Recommended Journals

    Journal of Cancer Chemotherapy Journal of Genetics and Molecular Biology Journal of Biology and Medicine Journal of Stem cell Research and Therapy

    Share this page

    Open Access Journals

    Journal of Mental Health and Psychiatry Journal of Cancer Chemotherapy Journal of Pediatrics Neonatal Biology Journal of Women Health Journal of Drug Discovery and Research Journal of Genetics and Molecular Biology Journal of Dental Sciences Journal of Bacteriology Parasitology Journal of Biology and Medicine Journal of Fermentation Technology Journal of Plant Pathology Journal of Stem cell Research and Therapy Journal of Medical Intelligence and Digital Health

    Jagdish Chand (PhD)

    Jagdish Chand

    Affiliation: Pharmaceutical Chemistry, JSS College of Pharmacy, Ooty

    University: JSS College of Pharmacy

    Department: Pharmaceutical Chemistry

    Email:

    Country: India

    Biography

    Dr. Jagdish Chand, PhD, specializes in the discovery and development of novel therapeutic molecules for neurological disorders, cancer, and diabetes, integrating both computational and experimental methodologies. His research focuses on bridging the gaps between biological pathways, cellular processes, and molecular functions, particularly in polygenic and rare diseases. He employs a comprehensive pipeline combining advanced in-silico techniques with organic synthesis and in vitro validation to translate computational insights into effective therapeutic strategies.